A vaccine against coronavirus could help beat lockdown and help life get back to normal – pharmaceutical giant Pfizer believes it’s close.
Since coronavirus emerged in January almost 200 vaccine candidates have been put into development, with at least 15 in human trials.
Vaccines being developed by Oxford University and in Germany could be ready this year, experts have said, but there are also candidates being tested in the US, Russia and China. There are also some signs that China is pulling ahead in the race.
But in an exciting development, 30 million doses of coronavirus vaccine could be heading to the UK before Christmas after US multinational Pfizer and German biotech firm BioNTech revealed on November 9 that their coronavirus vaccine was more than 90 per cent effective in preventing Covid-19 among those without evidence of prior infection.
Pfizer soared 13 per cent in pre-market trading after announcing its success in final stage clinical trials.
Boris Johnson said the Pfizer vaccine news was a sign the “scientific cavalry” was on its way, but stressed the need for caution.
Read More: How close is a Covid-19 vaccine after the Pfizer breakthrough – and who will get it first
